Bolt Biotherapeutics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BOLT Nasdaq 2836 https://boltbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bolt Biotherapeutics Inc

Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual Meeting - Mar 14th, 2023 8:30 pm
Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference - Feb 28th, 2023 1:00 pm
Bolt Biotherapeutics to Present at February Investor Conferences - Feb 1st, 2023 1:00 pm
Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation - Jan 4th, 2023 2:31 pm
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors - Dec 14th, 2022 9:43 pm
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update - Nov 10th, 2022 9:05 pm
Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting - Nov 7th, 2022 1:00 pm
Investors in Bolt Biotherapeutics (NASDAQ:BOLT) have unfortunately lost 89% over the last year - Nov 2nd, 2022 11:20 am
Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy? - Nov 1st, 2022 2:01 pm
Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference - Nov 1st, 2022 12:00 pm
16 Best Penny Stocks to Buy Now - Sep 9th, 2022 4:08 pm
Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference - Aug 31st, 2022 11:30 am
Eli Lilly (LLY) Stock Up More Than 15% YTD: What Lies Ahead? - Aug 25th, 2022 4:23 pm
J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli - Aug 25th, 2022 4:02 pm
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update - Aug 10th, 2022 8:05 pm
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans? - Jul 22nd, 2022 12:44 pm
Zacks.com featured highlights include Carriage Services, Pool, The Buckle, Bolt Biotherapeutics and Titan Machinery - Jun 10th, 2022 11:21 am
Bolt Biotherapeutics to Present Ex Vivo Data Characterizing the Myeloid Cell Landscape in Solid Tumors at ASCO 2022 - May 27th, 2022 12:00 pm
The past year for Bolt Biotherapeutics (NASDAQ:BOLT) investors has not been profitable - May 26th, 2022 10:52 am
The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma - May 13th, 2022 12:28 pm